Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Marc Coucke moest eens intresse krijgen ...... het zou beteren.
Geen zekerheid. Coucke heeft enkele jaren terug ook in mithra geïnvesteerd waarvan hij vorig jaar een deel percentage heeft afgebouwd. Kijk waar het nu staat.
Trading Expectations For The Upcoming Trading Day Of Monday 18th For the upcoming trading day on Monday 18th we expect Celyad SA to open at $1.63, and during day (based on 14 day Average True Range), to move between $1.53 and $1.69, which gives a possible trading interval of +/-$0.0769 (+/-4.77%) up or down from last closing price. If Celyad SA takes out the full calculated possible swing range there will be an estimated 9.55% move between the lowest and the highest trading price during the day. Since the stock is closer to the support from accumulated volume at $1.58 (1.86%) than the resistance at $1.93 (19.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
een duidelijk artikel ben benieuwd of dit wat gaat helpen qua koers ;) maar het kan maar zo deels zo uitpakken, dat stilzetten kan dus echt komen door de combi met het deel van Mercx, wel apart dat het zolang stil is hierover, en wat gaat de koers doen als blijkt dat niet aan Celyad ligt. Wel een hoopvol verhaal al met al, we gaan het wel zien wat het nog gaat brengen.
mocht er nu wel iets positiefs komen dan kan het maar zo eens worden overgenomen , dit vanwege de zeer lage koers.
Celyad nasdaq wel redelijk volume en groen. Hier ook wel meer volume,nog even 10k stuks die de boel ophouden en dan maar weer eens op naar de 1,75 a 1,90
Zulk volume da's lang geleden,maar wel weinig stijging.
Trading Expectations For The Upcoming Trading Day Of Tuesday 19th For the upcoming trading day on Tuesday 19th we expect Celyad SA to open at $1.63, and during day (based on 14 day Average True Range), to move between $1.57 and $1.73, which gives a possible trading interval of +/-$0.0764 (+/-4.63%) up or down from last closing price. If Celyad SA takes out the full calculated possible swing range there will be an estimated 9.27% move between the lowest and the highest trading price during the day. Since the stock is closer to the support from accumulated volume at $1.64 (0.61%) than the resistance at $1.93 (16.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance.
Trading Expectations For The Upcoming Trading Day Of Wednesday 20th For the upcoming trading day on Wednesday 20th we expect Celyad SA to open at $1.79, and during day (based on 14 day Average True Range), to move between $1.72 and $1.90, which gives a possible trading interval of +/-$0.0853 (+/-4.71%) up or down from last closing price. If Celyad SA takes out the full calculated possible swing range there will be an estimated 9.42% move between the lowest and the highest trading price during the day. Since the stock is closer to the resistance from accumulated volume at $1.93 (6.35%) than the support at $1.67 (7.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be hold until the stock is closer to the support level. Is Celyad SA stock A Buy? Celyad SA holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
gevonden op Boursorama : Celyad extrait de seeking alpha !ça pourrait être intèressant pour les finances ! le conditionnel est de mise ! Depuis mai 2018 et avec un avenant en 2022, Celyad a conclu des accords avec la société de biotechnologie australienne Mesoblast (MESO) pour développer et commercialiser un cathéter d'injection intra-myocardique. Celyad a reçu une commission initiale de 1 million de dollars en 2018. Dans le cadre de l'avenant de 2022, Celyad recevra 1,5 million de dollars d'actions ordinaires de Mesoblast (d'une valeur actuelle d'environ 4,5 millions de dollars), et Celyad pourra être éligible jusqu'à 20 millions de dollars en actions cliniques, réglementaires , et paiements d'étape commerciaux. Vertaling; uittreksel van seeking alpha! het kan interessant zijn voor financiën! de voorwaarde is in orde! Sinds mei 2018 en met een wijziging in 2022 heeft Celyad overeenkomsten gesloten met het Australische biotechnologiebedrijf Mesoblast (MESO) om een ??intra-myocardiale injectiekatheter te ontwikkelen en op de markt te brengen. Celyad ontving in 2018 een eerste commissie van $ 1 miljoen. Als onderdeel van het addendum voor 2022 zal Celyad $ 1,5 miljoen aan gewone Mesoblast-aandelen ontvangen (momenteel ongeveer 4,5 miljoen waard), en Celyad komt mogelijk in aanmerking voor maximaal $ 20 miljoen in klinische, regelgevende en commerciële mijlpaalbetalingen.
The Celyad SA stock price gained 1.66% on the last trading day (Wednesday, 20th Jul 2022), rising from $1.81 to $1.84. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 14.09% from a day low at $1.63 to a day high of $1.86. The price has risen in 5 of the last 10 days and is up by 16.46% over the past 2 weeks. Volume fell on the last day by -37 thousand shares and in total, 9 thousand shares were bought and sold for approximately $15.76 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.64% during the next 3 months and, with a 90% probability hold a price between $1.11 and $1.72 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Signals & Forecast A buy signal was issued from a pivot bottom point on Wednesday, July 06, 2022, and so far it has risen 16.46%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Celyad SA stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.85. On a fall, the stock will find some support from the short-term average at $1.69. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss Celyad SA finds support from accumulated volume at $1.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested. This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.23 between high and low, or 14.09%. For the last week the stock has had a daily average volatility of 7.25%. Our recommended stop-loss: $1.78 (-3.46%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 10 days ago.) Trading Expectations For The Upcoming Trading Day Of Thursday 21st For the upcoming trading day on Thursday 21st we expect Celyad SA to open at $1.78, and during day (based on 14 day Average True Range), to move between $1.74 and $1.94, which gives a possible trading interval of +/-$0.0957 (+/-5.20%) up or down from last closing price. If Celyad SA takes out the full calculated possible swing range there will be an estimated 10.41% move between the lowest and the highest trading price during the day. Since the stock is closer to the support from accumulated volume at $1.81 (1.63%) than the resistance at $1.93 (4.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Aan allen , ik ga stoppen met het zoeken naar informatie over Celyad , ik heb het gevoel dat het niet gewaardeerd wordt . Grt
Oh wattan Samos? Omdat er hier niet of nauwelijks reacties zijn? Het is en blijft afwachten met celyad.. koers doet weinig
Het schiet ook niet op he samos, zo staan we 5 procent rood en van de week 8 procent groen op nasdaq... maar er is geen pijl op te trekken, om hopende te worden...
SAMOS schreef op 21 juli 2022 14:44 :
Aan allen , ik ga stoppen met het zoeken naar informatie over Celyad , ik heb het gevoel dat het niet gewaardeerd wordt . Grt
Wow, heb je met alles wat je doet een aai over je bolletje nodig?
Zijn toch mensen die het leuk vinden om te laten zakken, 1 stuks verkoop voor 1,62. En dan ook nog zo eindigen vandaag toch triest zo
MaGu schreef op 22 juli 2022 09:17 :
[...]
Wow, heb je met alles wat je doet een aai over je bolletje nodig?
dan ben jij bij uitstek degene die mag aaien natuurlijk. Of blaas nog eens op je loftrompet voor de almachtige filipo.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee